Thu. 9 May 2024, 4:18pm ET
Benzinga
Earnings, Earnings Misses, News
Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.42) per share which met the analyst consensus estimate. This is a 16 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $715.000 thousand which missed the analyst consensus estimate of $2.075 million by 65.54 percent.